BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Wang Q, Zhang M, Zhang W, Zhao L, Yang C, Wang B, Jiang K, Ye Y, Shen Z, Wang S. Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing. Epigenetics 2021;16:425-35. [PMID: 32749190 DOI: 10.1080/15592294.2020.1805684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao K, Yang Z, Yan X, Liu Z, Yang M, Guo L, Cai L. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study. Front Bioeng Biotechnol 2022;10:846812. [DOI: 10.3389/fbioe.2022.846812] [Reference Citation Analysis]
2 Wang P, Liu T, Zhao Z, Wang Z, Liu S, Yang X. SPTBN2 regulated by miR-424-5p promotes endometrial cancer progression via CLDN4/PI3K/AKT axis. Cell Death Discov 2021;7:382. [PMID: 34887379 DOI: 10.1038/s41420-021-00776-7] [Reference Citation Analysis]
3 Li J, Liang L, Yang Y, Li X, Ma Y. N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction. Theranostics 2021;11:2581-93. [PMID: 33456561 DOI: 10.7150/thno.52366] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
4 Yue M, Liu T, Yan G, Luo X, Wang L. LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer. Cancer Cell Int 2021;21:504. [PMID: 34544413 DOI: 10.1186/s12935-021-02180-8] [Reference Citation Analysis]
5 Teng F, Tang W, Wuniqiemu T, Qin J, Zhou Y, Huang X, Wang S, Zhu X, Tang Z, Yi, Wei Y, Dong J. N 6-Methyladenosine Methylomic Landscape of Lung Tissues in Murine Acute Allergic Asthma. Front Immunol 2021;12:740571. [PMID: 34737744 DOI: 10.3389/fimmu.2021.740571] [Reference Citation Analysis]
6 Zhang N, Ding C, Zuo Y, Peng Y, Zuo L. N6-methyladenosine and Neurological Diseases. Mol Neurobiol 2022. [PMID: 35032318 DOI: 10.1007/s12035-022-02739-0] [Reference Citation Analysis]
7 Zhang L, Hao D, Ma P, Ma B, Qin J, Tian G, Liu Z, Zhou X. Epitranscriptomic Analysis of m6A Methylome After Peripheral Nerve Injury. Front Genet 2021;12:686000. [PMID: 34306026 DOI: 10.3389/fgene.2021.686000] [Reference Citation Analysis]
8 Tan C, Xia P, Zhang H, Xu K, Liu P, Guo D, Liu Z. YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner. Front Oncol 2022;12:873020. [DOI: 10.3389/fonc.2022.873020] [Reference Citation Analysis]
9 Zhao SY, Wang Z, Wu XB, Zhang S, Chen Q, Wang DD, Tan QF. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2. Kaohsiung J Med Sci 2022. [PMID: 35146902 DOI: 10.1002/kjm2.12503] [Reference Citation Analysis]
10 Han Z, Yang B, Wang Q, Hu Y, Wu Y, Tian Z. Comprehensive analysis of the transcriptome-wide m6A methylome in invasive malignant pleomorphic adenoma. Cancer Cell Int 2021;21:142. [PMID: 33653351 DOI: 10.1186/s12935-021-01839-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wu C, Dong B, Huang L, Liu Y, Ye G, Li S, Qi Y. SPTBN2, a New Biomarker of Lung Adenocarcinoma. Front Oncol 2021;11:754290. [PMID: 34745988 DOI: 10.3389/fonc.2021.754290] [Reference Citation Analysis]
12 Deng K, Ning X, Ren X, Yang B, Li J, Cao J, Chen J, Lu X, Chen S, Wang L. Transcriptome-wide N6-methyladenosine methylation landscape of coronary artery disease. Epigenomics 2021;13:793-808. [PMID: 33876670 DOI: 10.2217/epi-2020-0372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhou W, Wang X, Chang J, Cheng C, Miao C. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases. Crit Rev Clin Lab Sci 2021;:1-16. [PMID: 34775884 DOI: 10.1080/10408363.2021.2002256] [Reference Citation Analysis]
14 Feng P, Ge Z, Guo Z, Lin L, Yu Q. A Comprehensive Analysis of the Downregulation of miRNA-1827 and Its Prognostic Significance by Targeting SPTBN2 and BCL2L1 in Ovarian Cancer. Front Mol Biosci 2021;8:687576. [PMID: 34179092 DOI: 10.3389/fmolb.2021.687576] [Reference Citation Analysis]
15 Zhou Y, Yang J, Tian Z, Zeng J, Shen W. Research progress concerning m6A methylation and cancer. Oncol Lett 2021;22:775. [PMID: 34589154 DOI: 10.3892/ol.2021.13036] [Reference Citation Analysis]
16 Sun J, Ping Y, Huang J, Zeng B, Ji P, Li D. N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma. Front Cell Dev Biol 2021;9:705962. [PMID: 34422827 DOI: 10.3389/fcell.2021.705962] [Reference Citation Analysis]
17 Li S, Liu T, Li K, Bai X, Xi K, Chai X, Mi L, Li J. Spectrins and human diseases. Transl Res 2021:S1931-5244(21)00306-6. [PMID: 34979321 DOI: 10.1016/j.trsl.2021.12.009] [Reference Citation Analysis]
18 Sun D, Cai X, Shen F, Fan L, Yang H, Zheng S, Zhou L, Chen K, Wang Z. Transcriptome-Wide m6A Methylome and m6A-Modified Gene Analysis in Asthma. Front Cell Dev Biol 2022;10:799459. [DOI: 10.3389/fcell.2022.799459] [Reference Citation Analysis]
19 Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Lv X, Zou C. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. J Immunol Res 2021;2021:6149558. [PMID: 34476262 DOI: 10.1155/2021/6149558] [Reference Citation Analysis]
20 Li W, Chen G, Feng Z, Zhu B, Zhou L, Zhang Y, Mai J, Jiang C, Zeng J. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44. Genes Genomics 2021;43:1413-21. [PMID: 34677810 DOI: 10.1007/s13258-021-01175-z] [Reference Citation Analysis]